ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study

CONTEXT: Treatment delays can compromise outcomes in aggressive hematological malignancies primarily treated with chemotherapy. Due to the burden of the COVID-19 pandemic on healthcare systems, there is a potential risk of delayed therapy of various diseases, including cancers. However, efforts were...

Descripción completa

Detalles Bibliográficos
Autores principales: Anandaradje, Annuja, Goenka, Luxitaa, Dubashi, Biswajit, Kayal, Smita, Halanaik, Dhanapati, Basu, Debdatta, Ganesan, Prasanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Aggressive B-Cell Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404069/
http://dx.doi.org/10.1016/S2152-2650(21)01888-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404069/
http://dx.doi.org/10.1016/S2152-2650(21)01888-7

Ejemplares similares